The shares of this firm reacted sharply after it introduced its monetary outcomes. The monetary outcomes have drawn combined reactions from Dalal Road primarily based on this firm’s QoQ efficiency, which has hampered buyers’ confidence.
Value Motion
With a market capitalization of Rs 2,958 crore, the shares of Tanfac Industries Ltd is presently buying and selling at Rs 2,965 per share, down by 25.3 p.c, from its 52-week excessive of Rs 3,970. The inventory has given a optimistic return of 26.41 p.c within the final one yr.
Monetary Highlights
The corporate introduced its monetary outcomes and made a few bulletins final week. It reported a income of Rs 557 crores in FY25, up by 47.3 p.c from its FY24 income of Rs 378 crores. It elevated by 67 p.c YoY from 103 crores in This autumn FY24 to 172 crores in This autumn FY25. Nonetheless, on a QoQ foundation, it declined by 3.3 p.c from 178 crores in Q3 FY25 to 172 crores in This autumn FY25
It posted a web revenue of Rs 88 crores in FY25, up by 69 p.c, from its FY24 web revenue of Rs 52 crores. It elevated by 77 p.c YoY from 13 crores in This autumn FY24 to 23 crores in This autumn FY25. Nonetheless, on a QoQ foundation, it declined by 34 p.c from 35 crores in Q3 FY25 to 23 crores in This autumn FY25.
Moreover, the corporate has advisable a dividend of Rs 9 per fairness share, topic to the approval of shareholders on the Annual Basic Assembly of the Firm. As of This autumn FY25, Ashish Kacholia holds 1,58,229 shares of the corporate, representing an possession of 1.59 p.c.
Concerning the firm
Tanfac Industries Restricted, based in 1972 and situated in Chennai, produces and markets fluorine-based chemical substances inside India and exports to abroad nations. Merchandise embody hydrofluoric acid (dilute and anhydrous), oleum, sulphuric acid, aluminium and potassium fluoride, potassium bifluoride, boron trifluoride complexes, calcium sulphate, isobutyl acetophenone, acetic and peracetic acid, and poly aluminium chloride.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator usually are not accountable for any losses brought on because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
